112 related articles for article (PubMed ID: 34244118)
1. Prospective Longitudinal Health-related Quality of Life Analysis of the Finnish Arm of the PRIAS Active Surveillance Cohort: 11 Years of Follow-up.
Lokman U; Vasarainen H; Lahdensuo K; Erickson A; Muhonen T; Mirtti T; Rannikko A
Eur Urol Focus; 2022 Sep; 8(5):1151-1156. PubMed ID: 34244118
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
[TBL] [Abstract][Full Text] [Related]
3. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Bokhorst LP; Valdagni R; Rannikko A; Kakehi Y; Pickles T; Bangma CH; Roobol MJ;
Eur Urol; 2016 Dec; 70(6):954-960. PubMed ID: 27329565
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
[TBL] [Abstract][Full Text] [Related]
5. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
6. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with low-risk prostate cancer. A comparative retrospective study: brachytherapy versus robot-assisted laparoscopic prostatectomy versus active surveillance.
Acar C; Schoffelmeer CC; Tillier C; de Blok W; van Muilekom E; van der Poel HG
J Endourol; 2014 Jan; 28(1):117-24. PubMed ID: 23978277
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy.
Wallerstedt A; Nyberg T; Carlsson S; Thorsteinsdottir T; Stranne J; Tyritzis SI; Stinesen Kollberg K; Hugosson J; Bjartell A; Wilderäng U; Wiklund P; Steineck G; Haglind E
Eur Urol Focus; 2019 May; 5(3):389-398. PubMed ID: 29366855
[TBL] [Abstract][Full Text] [Related]
9. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
[TBL] [Abstract][Full Text] [Related]
11. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
[TBL] [Abstract][Full Text] [Related]
12. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
Eur Urol; 2015 Mar; 67(3):432-8. PubMed ID: 24582327
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
14. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up.
Lantz A; Bock D; Akre O; Angenete E; Bjartell A; Carlsson S; Modig KK; Nyberg M; Kollberg KS; Steineck G; Stranne J; Wiklund P; Haglind E
Eur Urol; 2021 Nov; 80(5):650-660. PubMed ID: 34538508
[TBL] [Abstract][Full Text] [Related]
15. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
Hirama H; Sugimoto M; Miyatake N; Kato T; Venderbos LDF; Remmers S; Shiga K; Yokomizo A; Mitsuzuka K; Matsumoto R; Osawa T; Abe T; Sasaki H; Egawa S; Ninomiya I; Hashine K; Roobol MJ; Kakehi Y
World J Urol; 2021 Jul; 39(7):2491-2497. PubMed ID: 33079252
[TBL] [Abstract][Full Text] [Related]
17. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
19. Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.
Bokhorst LP; Alberts AR; Rannikko A; Valdagni R; Pickles T; Kakehi Y; Bangma CH; Roobol MJ;
Eur Urol; 2015 Nov; 68(5):814-21. PubMed ID: 26138043
[TBL] [Abstract][Full Text] [Related]
20. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance.
Bellardita L; Rancati T; Alvisi MF; Villani D; Magnani T; Marenghi C; Nicolai N; Procopio G; Villa S; Salvioni R; Valdagni R
Eur Urol; 2013 Jul; 64(1):30-6. PubMed ID: 23357351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
